Vaccines, Blood & Biologics
-
Telephone Conference Memorandum - 8/3/2007 - AFLURIA
TELEPHONE CONFERENCE MEMORANDUM
| STN 125254/0: | CTD BLA for Influenza Virus Vaccine |
| SPONSOR: | CSL Limited |
| PRODUCT: | Influenza Virus Vaccine |
| DATE: | August 3, 2007 |
CBER REPRESENTATIVE:
Katherine Berkhousen
Rakesh Pandey
CSL REPRESENTATIVE:
Paul Hartman
Tel: 610-878-4644
SUMMARY:
CSL contacted to discuss the following CMC concerns:
- --------------------------------------------------------------------------------------------------------------------------------------
--------------------------------------------------------------------------------------------------------------------------------------
--------------------------------------------------------------------------------------------------------------------------------------
--------------------------------------------------------------------------------------------------------------------------------------
--------------------------------------------------------------------------------------------------------------------------------------
--------------------------------------------------------------------------------------------------------------------------------------
--------------------------------------------------------------- - --------------------------------------------------------------------------------------------------------------------------------------
--------------------------------------------------------------------------------------------------------------------------------------
--------------------------------------------------------------------------------------------------------------------------------------
--------------------------------------------------------------------------------------------------------------------------------------
--------------------------------------------------------------------------------------------------------------------------------------
--------------------------------------------------------------------------------------------------------------------------------------
--------------------------------------------------------------------------------------------------------------------------------------
--------------------------------------------------------------------------------------------------------------------------------------
--------------------------------------------------------------------------------------------------------------------------------------
--------------------------------------------------------------------------------------------------------------------------------------
--------------------------------------------------------------------------------------------------------------------------------------
--------------------------------------------------------------------------------------------------------------------------------------
------------------------ - --------------------------------------------------------------------------------------------------------------------------------------
-------------------------------------------------------------------------------------------------------------------------------
-
-
